Jacobs Levy Equity Management
AGN

Jacobs Levy Equity Management’s Allergan plc AGN Stock Holding History

Jacobs Levy Equity Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-354,620
Closed -$51.9M – 1077
2019
Q1 		$51.9M Buy
354,620
+53,520
+18% +$7.76M 0.75% 11
2018
Q4 		$40.2M Buy
301,100
+98,170
+48% +$16.1M 0.71% 20
2018
Q3 		$38.7M Buy
202,930
+30,130
+17% +$5.54M 0.55% 32
2018
Q2 		$28.8M Sell
172,800
-1,110
-0.6% -$178K 0.45% 46
2018
Q1 		$29.3M Buy
173,910
+29,039
+20% +$4.87M 0.49% 37
2017
Q4 		$23.7M Buy
144,871
+30,730
+27% +$5.51M 0.42% 61
2017
Q3 		$23.4M Buy
+114,141
New +$26.5M 0.45% 54
2017
Q1 		– Sell
-3,470
Closed -$729K – 1054
2016
Q4 		$729K Buy
+3,470
New +$719K 0.01% 613
2016
Q3 		– Sell
-10,230
Closed -$2.36M – 1189
2016
Q2 		$2.36M Buy
+10,230
New +$2.36M 0.05% 389
2013
Q3 		– Sell
-9,340
Closed -$1.18M – 1050
2013
Q2 		$1.18M Buy
+9,340
New +$1.06M 0.02% 530

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jacobs Levy Equity Management's AGN Position: Q2 2019 in Review

Jacobs Levy Equity Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 354,620 shares — an estimated $51.9M sold.

Jacobs Levy Equity Management first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $51.9M in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Jacobs Levy Equity Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 354,620 Allergan plc shares in Q2 2019, an estimated $51.9M.
  • Jacobs Levy Equity Management first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
  • Jacobs Levy Equity Management's Allergan plc position peaked at $51.9M in Q1 2019.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.